In an unusual twist, New York University took in more from licenses on its inventions than it spent on all of its research in the 2007 fiscal year.

The details, as well as information on the patenting and licensing activities of 153 other colleges and universities, are available in a Chronicle chart. [Update (1/29): This chart, as originally posted, contained erroneous data. The chart has now been reposted with corrected data.]

The chart also includes information on start-up companies created by each of the reporting institutions, the number of deals they executed, the number of patents they filed for, and other telling statistics that relate to activities by colleges’ offices of technology transfer.

The statistics are among those measured by the Association of University Technology Managers in a new report out today. (Some institutions participated in the association’s survey but asked to keep their data private; the chart omits them as well as institutions that did not provide data for the categories listed.)

By the way, NYU ranks first on the chart, with licensing revenues of more than $791-million, largely because of a deal it made in May 2007 to sell a portion of its future rights to royalties on an anti-inflammatory drug called Remicade for $650-million.

For comparisons to the prior year, see this chart of the biggest earners. —Goldie Blumenstyk